Keyphrases
Tuberculosis
100%
Mycobacterium Tuberculosis (M. tb)
43%
Texas
41%
United States
28%
Latent Tuberculosis Infection
27%
Tuberculosis Treatment
25%
Atherosclerosis Prevention
24%
Air Force
24%
Coronary Atherosclerosis
24%
Prevention Studies
24%
Lovastatin
22%
Tuberculosis Patients
19%
Rifapentine
18%
High-density Lipoprotein Cholesterol (HDL-C)
18%
Pulmonary Tuberculosis
17%
Confidence Interval
16%
Directly Observed Therapy
15%
Pulmonary Dysfunction
15%
CD8+ T Cells
14%
Tuberculin Skin Test
13%
Low-density Lipoprotein Cholesterol (LDL-C)
12%
Antiretroviral Therapy
12%
Tuberculosis Diagnosis
12%
T Cells
12%
Placebo
12%
Major Coronary Events
11%
HIV Patients
11%
Cholesterol
10%
Primary Prevention
10%
Relative Risk
9%
High Risk
9%
Gemfibrozil
9%
Statin Therapy
9%
HIV Infection
8%
Multidrug-resistant Tuberculosis (MDR-TB)
8%
Once-weekly
8%
Odds Ratio
8%
Canada
7%
CD4+
7%
Treatment Completion
7%
AIDS/HIV
7%
CD4 Count
7%
Immunosuppressive Therapy
7%
Intracellular Pathogen
7%
Drug Resistance
7%
Interleukin-18 (IL-18)
7%
Acute Coronary Event
6%
Tolerability
6%
IS6110
6%
Statins
6%
Medicine and Dentistry
Tuberculosis
32%
Human Immunodeficiency Virus
27%
Disease
26%
Lung Tuberculosis
18%
Mycobacterium Tuberculosis
15%
Latent Tuberculosis
14%
Lovastatin
13%
Directly Observed Therapy
12%
Placebo
10%
Tuberculosis Treatment
10%
Primary Prevention
8%
Health Care Cost
8%
Low Density Lipoprotein Cholesterol
7%
Drug Therapy
7%
Isoniazid
7%
Pathogen
7%
High Density Lipoprotein Cholesterol
7%
Primary Health Care
7%
Foreign Born
6%
Immigrant
6%
Tuberculin
6%
Odds Ratio
6%
Anus Carcinoma
6%
Drug Resistance
6%
T Cell
6%
Skin Test
6%
Ingestion
6%
Cell Count
5%
Promoter Region
5%
Infectious Disease Treatment
5%
Mantoux Test
5%